Cancer Immunotherapy 101 (Aug 18, 2016)
In-Person Event
Aug 18, 2016
New York, New York, USASpeakers
OVERVIEW
Cancer Immunotherapy 101 (Aug 18, 2016) is organized by Society for Immunotherapy of Cancer (SITC) and would be held on Aug 18, 2016 at New York, New York, United States of America.
The targeted audience for this medical event basically for clinical oncologists, nurses, pharmacists and the entire medical team involved in treating cancer patients with immunotherapy, this introductory, CME- and CE-certified program provides an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy for melanoma, lung cancer and genitourinary cancers.
Presented by leading authorities in tumor immunology and cancer immunotherapy, this program will facilitate understanding of :
1) The basic principles of tumor immunology and immunotherapy,
2) The clinical indications for immunotherapy and the appropriate selection and management of patients,
3) Emerging concepts and agents in the cancer immunotherapy field, and
4) The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.
Attendees may also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.
Educational Objectives are :
* Discuss the key mechanisms and terminology of tumor immunology and immunotherapy
* Describe the role of immunity in cancer and approaches to tumor immunotherapy
*Implement cancer immunotherapy treatments for melanoma, lung cancer and/or genitourinary cancers into clinical practice more effectively through a sound understanding of mechanisms of action, side effects and clinical management, and efficacy
*Provide appropriate care and counsel for patients and their families
*Provide accurate and appropriate counsel as part of the treatment team.
The targeted audience for this medical event basically for clinical oncologists, nurses, pharmacists and the entire medical team involved in treating cancer patients with immunotherapy, this introductory, CME- and CE-certified program provides an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy for melanoma, lung cancer and genitourinary cancers.
Presented by leading authorities in tumor immunology and cancer immunotherapy, this program will facilitate understanding of :
1) The basic principles of tumor immunology and immunotherapy,
2) The clinical indications for immunotherapy and the appropriate selection and management of patients,
3) Emerging concepts and agents in the cancer immunotherapy field, and
4) The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.
Attendees may also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.
Educational Objectives are :
* Discuss the key mechanisms and terminology of tumor immunology and immunotherapy
* Describe the role of immunity in cancer and approaches to tumor immunotherapy
*Implement cancer immunotherapy treatments for melanoma, lung cancer and/or genitourinary cancers into clinical practice more effectively through a sound understanding of mechanisms of action, side effects and clinical management, and efficacy
*Provide appropriate care and counsel for patients and their families
*Provide accurate and appropriate counsel as part of the treatment team.
KEY DATES
18 Aug, 2016
Event Start Date
18 Aug, 2016
Event End Date
SPECIALITIES
Immunology and MicrobiologyNursingOncologySUGGESTED HOTELS
CONFERENCE VENUE
TBDRELATED CONFERENCES & LIVE WEBINARS
Quick Links